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Abstract 
Background: Radiolabeled RGD peptides detect αvβ3 integrin expression associated with angiogenesis and extracel‑
lular matrix remodeling after myocardial infarction. We studied whether cardiac positron emission tomography (PET) 
with  [68Ga]NODAGA‑RGD detects increased αvβ3 integrin expression after induction of flow‑limiting coronary stenosis 
in pigs, and whether αvβ3 integrin is expressed in viable ischemic or injured myocardium.
Methods: We studied 8 Finnish landrace pigs 13 ± 4 days after percutaneous implantation of a bottleneck stent in 
the proximal left anterior descending coronary artery. Antithrombotic therapy was used to prevent stent occlusion. 
Myocardial uptake of  [68Ga]NODAGA‑RGD (290 ± 31 MBq) was evaluated by a 62 min dynamic PET scan. The ischemic 
area was defined as the regional perfusion abnormality during adenosine‑induced stress by  [15O]water PET. Guided 
by triphenyltetrazolium chloride staining, tissue samples from viable and injured myocardial areas were obtained for 
autoradiography and histology.
Results: Stent implantation resulted in a partly reversible myocardial perfusion abnormality. Compared with remote 
myocardium,  [68Ga]NODAGA‑RGD PET showed increased tracer uptake in the ischemic area (ischemic‑to‑remote ratio 
1.3 ± 0.20, p = 0.0034). Tissue samples from the injured areas, but not from the viable ischemic areas, showed higher 
 [68Ga]NODAGA‑RGD uptake than the remote non‑ischemic myocardium. Uptake of  [68Ga]NODAGA‑RGD correlated 
with immunohistochemical detection of αvβ3 integrin that was expressed in the injured myocardial areas.
Conclusions: Cardiac  [68Ga]NODAGA‑RGD PET demonstrates increased myocardial αvβ3 integrin expression after 
induction of flow‑limiting coronary stenosis in pigs. Localization of  [68Ga]NODAGA‑RGD uptake indicates that it 
reflects αvβ3 integrin expression associated with repair of recent myocardial injury.
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Background
Integrins are heterodimeric transmembrane glycopro-
tein receptors that mediate interactions between cells 
and their surroundings [1, 2]. Imaging of radiolabelled 
arginyl-glycyl-aspartic acid (RGD) motif containing 
peptides targeting the αvβ3 integrin has demonstrated 
enhanced myocardial αvβ3 integrin expression after 
ischemic myocardial injury [3–15]. The αvβ3 integrin is 
expressed in cardiac myofibroblasts [10, 16] and mac-
rophages [17] involved in extracellular matrix (ECM) 
remodeling as well as in vascular endothelial cells during 
angiogenesis [3–9, 11, 13, 18], i.e. the formation of new 
microvascular networks from pre-existing capillaries. 
Since ECM remodeling and angiogenesis are essential 
for the healing of ischemic injury αvβ3 integrin expres-
sion has been proposed as a marker of myocardial repair 
[3, 18]. However, it remains unknown to what extent 
the αvβ3 integrin is expressed in response to chronic 
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flow-limiting coronary stenosis and whether αvβ3 integ-
rin expression is induced in viable or irreversibly injured 
myocardium. We hypothesized that in addition to the 
injured myocardium ischemia induces angiogenesis 
and αvβ3 integrin expression also in the viable ischemic 
myocardium.
In order to study the effects of flow-limiting coro-
nary stenosis on myocardial expression of αvβ3 integrin, 
we performed cardiac positron emission tomography 
(PET) with 68Gallium-labeled 1,4,7-triazacyclononane-
1-glutaric acid-4,7-diacetic acid conjugated RGD pep-
tide  ([68Ga]NODAGA-RGD), a myocardial perfusion 
PET, and a histological evaluation of myocardial injury 
and αvβ3 integrin expression in pigs. We induced ste-
nosis by percutaneous implantation of a bottleneck 
stent in the proximal left anterior descending (LAD) 
coronary artery that has been shown to induce severe 
reduction in myocardial perfusion, rapid collateral 
formation and some degree of irreversible myocar-
dial injury [19]. We compared  [68Ga]NODAGA-RGD 
uptake in the ischemic myocardium and the remote 
non-ischemic myocardium as well as in the viable and 
injured ischemic myocardial areas 2  weeks after the 
induction of stenosis.
Methods
Animals and study protocol
Coronary stenosis was created in 11 domestic, 3-month 
old pigs weighing 30–35 kg by implanting a bottleneck 
stent in the proximal LAD coronary artery as described 
previously [19]. In addition, a sham group of 4 pigs 
underwent a catheterization procedure without the 
stent implantation. Myocardial  [68Ga]NODAGA-RGD 
uptake was evaluated by PET 13 ± 4 days after the stent 
implantation. In the same imaging session, myocardial 
perfusion was quantified using  [15O]water PET (physi-
cal half-life 2 min) at rest and during adenosine-induced 
stress before a  [68Ga]NODAGA-RGD (physical half-life 
68  min) injection to localize the myocardium and to 
determine the ischemic area. Three pigs without a per-
fusion defect during adenosine stress were considered 
as procedural failures and excluded from further in vivo 
analyses.
Subsequently, the pigs were euthanized and their 
hearts were excised. Based on 1% 2,3,5-triphenyltetra-
zolium chloride (TTC) (Sigma-Aldrich, Saint Louis, 
MO, USA) staining, tissue samples were obtained from 
the injured ischemic (TTC negative) and adjacent viable 
ischemic (TTC positive) myocardium as well as from the 
remote non-ischemic myocardium. Autoradiography of 
myocardial tissue sections was used to compare  [68Ga]
NODAGA-RGD uptake with the histology, αvβ3 integrin 
expression and CD31 on endothelial cells.
Anesthesia and hemodynamic monitoring
Prior to the cardiac catheterization and imaging studies, 
the animals were anesthetized with midazolam 1 mg/kg 
(Midazolam Hameln, Hameln Pharmaceuticals GmbH, 
Hameln, Germany) and xylazine 4  mg/kg (Rompun vet, 
Bayer Animal Health GmbH, Leverkusen, Germany) 
intramuscularly (i.m), connected to a respirator (Dräger 
Oxylog 3000, Drägerwerk AG, Lübeck, Germany) and 
ventilated mechanically (tidal volume 8–10  ml/kg, fre-
quency 14–18 breaths per minute). The ear vein was 
cannulated using a 22G venous catheter and anesthesia 
was maintained with intravenous (i.v.) infusion of propo-
fol 10–50  mg/kg/h (Propofol-Lipuro, B. Braun Melsun-
gen AG, Melsungen, Germany) combined with fentanyl 
4–8 µg/kg/h (Fentanyl-Hameln, Hameln Pharmaceuticals 
GmbH, Hameln, Germany). Cefuroxime (Zinacef, Glaxo-
SmithKline, Brentford, UK) was given 750 mg i.v. before 
catheterization.
The femoral artery was cannulated for hemodynamic 
monitoring during imaging studies. Diastolic, systolic 
and mean arterial pressure and heart rate were recorded 
using a pressure transducer (TruWave, Edwards Lifes-
ciences, Irvine, CA, USA) connected to an anesthesia 
monitor.
Coronary stenosis model
The bottleneck stent was prepared and implanted as pre-
viously described [19]. In brief, an introducer sheath (6F, 
Cordis, Bridgewater, NJ, USA) was placed percutaneously 
in the femoral artery. Catheterization of the pigs was per-
formed in an angiographic laboratory equipped with a 
GE Innova  3100IQ three-dimensional (3-D) angiography 
device (GE Healthcare, Waukesha, WI, USA). To create 
a coronary stenosis, a sterilized polytetrafluoroethyl-
ene tube (diameter 5/64 in.; Fluorplast, Petalax, Finland) 
with a bottleneck diameter of 0.9 mm was inserted on a 
Coroflex Blue Ultra (B. Braun Medical; profile 0.8  mm) 
bare metal stent. The bottleneck stent was placed into 
the proximal LAD. The correct positioning and patency 
of the bottleneck stent was confirmed by X-ray fluoros-
copy, the sheath was removed and the Femostop device 
(St. Jude Medical, St. Paul, MN, USA) was used to secure 
hemostasis.
To prevent ischemia-induced arrhythmias, administra-
tion of amiodarone 200  mg/day per orally (p.o.) (Cord-
arone, Sanofi, Paris, France) and bisoprolol 2.5  mg/day 
p.o. (Bisoproact, Actavis Group, Hafnarfjordur, Island) 
were administered starting 1  week before the proce-
dure until the end of the study. Immediately before stent 
implantation, the pigs also received a 100 mg i.v. bolus of 
lidocaine (Lidocain, Orion Corporation, Espoo, Finland) 
and 2.5 ml i.v. bolus of magnesium sulphate (246 mg/ml, 
Addex-magnesiumsulfaatti, Fresenius Kabi AB, Uppsala, 
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Sweden). To prevent thrombotic occlusion of the bot-
tleneck stent, acetylsalicylic acid 300  mg p.o. (Primas-
pan, Orion Corporation, Espoo, Finland) and clopidogrel 
300  mg p.o. (Plavix, Sanofi, Paris, France) were given 
1  day before stenting. Furthermore, enoxaparin 30  mg 
i.v. (Sanofi, Paris, France) was administered after the 
insertion of an introducer sheath in the femoral artery, 
and another 30 mg was given subcutaneously (s.c.) after 
removing the sheath and securing hemostasis. Daily 
doses of acetylsalicylic acid (100 mg/day p.o.), clopidogrel 
(75  mg/day p.o.), and enoxaparin (30  mg/day  s.c.) were 
continued throughout the study.
Radiochemistry
1,4,7-Triazacyclononane-1-glutaric acid-4,7-diacetic 
acid conjugated RGD peptide (cyclo[L-arginylglycyl-L-
a-aspartyl-d-tyrosyl-N6-([[4,7-bis(carboxymethyl)-1,4,7-
triazonan-1-yl]acetyl])-l-lysyl]; NODAGA-RGD) was 
purchased from ABX advanced biochemical compounds 
GmbH (product number 9805; Radenberg, Germany). 
68Ga was obtained from a 68Ge/68Ga generator (Eckert & 
Ziegler, Valencia, CA, USA) by elution with 0.1 M hydro-
chloric acid. 68Ga-eluate (500 μl) was mixed with sodium 
acetate (18  mg) to give a pH of approximately 5. Then, 
NODAGA-RGD (10  nmol, dissolved in deionized water 
to give stock solution of 1  mM) was added. The reac-
tion mixture was heated at 100 °C for 15 min. No further 
purification was performed. The radiochemical purity 
of  [68Ga]NODAGA-RGD was determined by reversed-
phase high-performance liquid chromatography (RP-
HPLC) with a Jupiter C18 column (4.6 ×  150  mm, 300 
Å, 5 μm; Phenomenex, Torrance, CA, USA). The HPLC 
conditions were as follows: flow rate  =  1  ml/min, 
λ = 220 nm. The gradient system was: A = 0.1% trifluoro-
acetic acid (TFA) in water; B = 0.1% TFA in acetonitrile. 
The A/B gradient was: 0–5  min 97/3, 5–15  min from 
97/3 to 0/100. The HPLC system consisted of LaChrom 
Instruments (Hitachi; Merck, Darmstadt, Germany) cou-
pled with a flow-through Radiomatic 150TR radioisotope 
detector (Packard, Meriden, CT, USA).
In vitro plasma protein binding
To evaluate species-dependent differences, the  [68Ga]
NODAGA-RGD binding to human, pig and rat plasma 
proteins was measured using in vitro assay as described 
previously [20].
PET image acquisition and reconstruction
All the animals first underwent a myocardial perfusion 
PET study with  [15O]water at rest and under pharmaco-
logical stress as previously described [21] with a Discov-
ery 690 hybrid PET/CT scanner (GE Medical Systems, 
Milwaukee, WI, USA).  [15O]water (760 ± 130 MBq) was 
injected as an i.v. bolus over 15  s at an infusion rate of 
10  ml/min via the ear vein. A dynamic acquisition of 
4 min 40 s was performed (time frames 14 × 5 s, 3 × 10 s, 
3 × 20 s and 4 × 30 s) in 3D mode. An adenosine infu-
sion at the rate of 200–500  µg/kg/min combined with 
phenylephrine 5 µg/kg/min was started 120 s before the 
 [15O]water injection and continued until the end of the 
scan. The acquired  [15O]water PET data were corrected 
for scatter, random counts and dead time, and recon-
structed with an iterative VUE Point algorithm using 2 
iterations and 24 subsets. The device produces 47 axial 
planes with a slice thickness of 3.27 mm.
Then a  [68Ga]NODAGA-RGD PET was performed with 
an ECAT EXACT HR+ scanner (Siemens-CTI, Knox-
ville, TN, USA). The studies were started with a 10 min 
transmission scan. The dynamic scanning started at the 
same time as 310  ±  43  MBq (230–400  MBq) of  [68Ga]
NODAGA-RGD was injected via the ear vein. The acqui-
sition time frames were as follows: 18 × 10 s, 4 × 30 s, 
2 × 120 s, 1 × 180 s, 4 × 300 s, 3 × 600 s (total duration 
62  min). The acquired  [68Ga]NODAGA-RGD PET data 
were corrected for scatter, random counts, and dead time 
and iteratively reconstructed with ordered-subsets expec-
tation maximization (OSEM) algorithm using 2 iterations 
and 32 subsets. The whole transaxial field of view (70 cm) 
was reconstructed in 256 × 256 matrix yielding to pixel 
size of 2.57 mm × 2.57 mm. The device produces 63 axial 
planes with a slice thickness of 2.43 mm.
PET image analysis
PET image analysis was done with Carimas 2.9 software 
(Turku PET Centre, Turku, Finland) using Heart and Polar-
Roi plug-in tools as described earlier [21, 22]. After man-
ual definition of the long axis, the myocardial contours in 
the  [15O]water images were semi-automatically defined. In 
order to obtain myocardial time-activity curves (TAC; the 
radioactivity concentrations as a function of time after the 
tracer injection), the PET data were volumetrically sam-
pled and the volume of interest (VOI) covering the whole 
left ventricle (LV) myocardium was applied to the dynamic 
imaging series. The arterial input function was measured 
in a VOI centered in the basal part of the LV cavity. The 
regional LV myocardial blood flow (MBF) was quanti-
fied in  [15O]water data as ml/min/g using a conventional 
single-compartment model and displayed as a parametric 
polar map with a standard 17 segments. The polar maps 
were normalized to one segment (segment 11) in the pos-
terolateral wall that was always outside the ischemic area. 
The ischemic area was defined as a region with myocardial 
blood flow less than 80% of maximum during adenosine-
induced stress as previously described [22].
For quantification of  [68Ga]NODAGA-RGD uptake in 
the myocardium, the  [15O]water images and the  [68Ga]
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NODAGA-RGD images were co-registered using the 
high blood pool activity of the  [68Ga]NODAGA-RGD 
as a landmark (Fig.  1). The myocardial contours from 
the  [15O]water images were copied to the co-registered 
 [68Ga]NODAGA-RGD data. Then, the polar maps of 
 [68Ga]NODAGA-RGD uptake expressed as standardized 
uptake value (SUV) (time frame 52–62  min after injec-
tion) in the LV myocardium were generated using match-
ing image orientation and sampling points. The region of 
interest (ROI) defining the ischemic area was copied from 
the  [15O]water polar maps to measure  [68Ga]NODAGA-
RGD uptake in this region. The septum was excluded 
from the measurements to prevent spillover from the 
blood in the right ventricle. The mean and maximum 
SUVs were determined from the ischemic area. In order 
to measure the SUVs, ROI was modified to include only 
the mid-myocardium in order to avoid spill-over from 
blood. The maximum SUV within the ROI was deter-
mined from area showing visually the highest uptake. 
One segment in the posterolateral wall (segment 11) that 
was always outside the ischemic area was used to meas-
ure  [68Ga]NODAGA-RGD uptake in the remote myocar-
dium. The ischemic-to-remote SUV ratio was calculated 
in the ischemic area and remote myocardium.
Blood sampling and analyses
During the  [68Ga]NODAGA-RGD PET imaging, blood 
samples (2  ml) were obtained into heparinized tubes 
from the femoral artery 2, 5, 10, 20, 30, 40, 50 and 60 min 
after the injection of  [68Ga]NODAGA-RGD for the 
measurements of total radioactivity, radiometabolites 
(proportion of authentic tracer), and plasma-to-blood 
ratio. The radioactivities of whole blood and blood 
plasma were measured using a gamma counter (1480 
Wizard 3″; PerkinElmer, Turku, Finland).
Tissue sampling, autoradiography and histology
Immediately after the PET scanning, the animals were 
sacrificed by an i.v. injection of potassium chloride (B. 
Braun Medical Oy, Helsinki, Finland). The heart was 
excised, the LV was cut into 4 short axis slices from 
base to apex that were incubated for 15 min in 1% TTC 
(Sigma-Aldrich, Saint Louis, MO, USA), diluted in phos-
phate-buffered saline (pH 7.4) at 37  °C, photographed 
from both sides and the presence of non-viable ischemic 
area was confirmed visually. Based on the TTC staining, 
transmural samples containing non-viable and imme-
diately adjacent viable myocardium were collected from 
the LV wall corresponding to the ischemic area in PET 
images. Another sample was obtained from the poste-
rior LV wall representative of the remote region (segment 
number 11).
Myocardial samples and a blood sample were weighed 
and measured for radioactivity using the gamma counter 
(Wizard). The radioactivity concentration was expressed 
as standardized uptake values (SUV = ([tissue radioactiv-
ity/tissue weight]/[total given radioactivity/animal body 
weight])).
Tissue samples were frozen in isopentane mixed with 
dry ice and cut into serial 40 and 7 µm sections for auto-
radiography and immunohistochemical stainings respec-
tively, using a cryomicrotome. Tissue sections of 40 μm 
Fig. 1 Co‑registration of  [68Ga]NODAGA‑RGD and  [15O]water PET images and definition of myocardial contours. a and f demonstrate  [68Ga]
NODAGA‑RGD images during the first 2 min after injection of the tracer, b and g demonstrate the fusion of  [15O]water PET images (c, h) and  [68Ga]
NODAGA‑RGD images used in the co‑registration (a, f). Yellow lines represent myocardial contours defined in  [15O]water PET images and copied to 
the  [68Ga]NODAGA‑RGD images. d and i demonstrate the fusion of the  [15O]water PET images (c, h) and  [68Ga]NODAGA‑RGD images during the 
last 20 min of the imaging session (e, j) that demonstrate higher activity in the ischemic area in the anteroseptal wall as compared with the remote 
myocardium in the inferoposterior wall
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thickness were immediately exposed on a phosphor 
imaging plate (BAS-TR2025, Fuji Photo Film Co. Ltd., 
Tokyo, Japan) for 2  h. The distribution of radioactivity 
on the plate was visualized and quantified using a Fluo-
rescent Image Analyzer (Fujifilm FLA-5100, Fuji Photo 
Film Co. Ltd., Tokyo, Japan). Autoradiographs and hema-
toxylin & eosin (HE) staining images of the same sections 
were co-registered and  [68Ga]NODAGA-RGD accumu-
lation was measured by drawing ROIs covering remote 
myocardium, and either viable or injured ischemic myo-
cardium using TINA™ 2.10f software (Raytest Isotopen-
messgeräte GmbH., Straubenhardt, Germany). Results 
were expressed as photostimulated luminescence per 
square millimetre (PSL/mm2) and normalized for the 
injected radioactivity dose, animal weight and the radio-
activity decay.
Serial tissue sections of 7  μm were stained with H&E 
for general histology, Masson’s trichrome for differentia-
tion myocytes and collagenous scar, and immunohisto-
chemistry with antibodies against of CD31 on endothelial 
cells (dilution 1:250, Thermo Scientific, Cheshire, UK), 
αvβ3 integrin (dilution 1:200, Millipore, Temecula, CA, 
USA) and α-smooth muscle actin on myofibroblasts 
(dilution 1:30,000, Sigma-Aldrich, St. Louis, MO, USA). 
Envision (Dako, Glostrup, Denmark) and Vectastain ABC 
(Vector Laboratories, Burlingame, CA, USA) kits were 
used for detection, respectively.
Statistical analyses
All data are expressed as mean ± SD. Statistical analysis 
was done with SPSS Statistics software v. 21 (IBM, NY, 
USA). A paired Student’s t test was applied for compari-
sons of the values between ischemic and remote areas. 
Comparisons of viable ischemic, injured ischemic and 
remote areas were done using ANOVA with Dunnett’s 
correction for remote group. A Pearson’s rank test (r) was 
used to analyze correlation between autoradiography and 
αvβ3 integrin immunohistochemistry. p values less than 
0.05 were considered statistically significant.
Results
All the pigs survived the follow-up period. As shown 
in Fig.  2, perfusion imaging with  [15O]water PET dur-
ing adenosine stress showed a regional perfusion defect 
corresponding to the ischemic myocardium subtended 
by the stented LAD in 8 pigs that formed the final study 
group.
Myocardial blood flow
The average size of the ischemic area defined as 
MBF  <  80% of the maximum during adenosine stress 
was 30 ± 10% of the LV as shown in Table 1. There was 
a regional reduction in resting perfusion within the 
ischemic area in 2 pigs showing reversible abnormality 
in the border areas. The average MBF in the ischemic 
area was lower than in the remote myocardium both at 
rest (1.4 ± 0.46 vs. 1.6 ± 0.41 ml/g/min, p = 0.0026) and 
during adenosine stress (1.9  ±  1.1 vs. 4.0  ±  2.2  ml/g/
min, p =  0.0036). The average rate pressure product at 
rest and during adenosine stress was 14,000 ± 4500 and 
14,000 ± 3700 mmHg bpm, respectively.
Histology
In 6 pigs TTC staining showed partially injured myo-
cardium within the ischemic area. In 4 pigs there was 
subendocardial injury within 1 or 2 segments, and in 2 
pigs there was partially transmural injury extending to 3 
segments.
Histological findings in tissue samples from the remote 
area and viable ischemic or injured area are described 
in Figs.  3 and 4. Tissue sections from the injured area 
showed characteristic histological features of recent 
ischemic myocardial injury. There was mainly loose con-
nective tissue with some mature collagen fibers among 
Fig. 2 Cardiac  [68Ga]NODAGA‑RGD and  [15O]water in vivo PET analyses. a and b demonstrate polar maps of MBF measured by  [15O]water PET 
at rest and during adenosine stress, respectively. c and d show polar maps of  [68Ga]NODAGA‑RGD uptake. Note the presence of increased  [68Ga]
NODAGA‑RGD uptake in c co‑localizing with an area of reduced myocardial perfusion (asterisk in a, b) as compared with the remote area (arrow-
head in a, b). Distribution of  [68Ga]NODAGA‑RGD is homogenous in the left ventricle of sham operated pig (d)
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a large amount of myofibroblasts and inflammatory 
cells. Viable ischemic areas showed normal distribution 
of myocytes and connective tissue, but some myocyte 
vacuolization probably related to ischemia was seen. The 
remote myocardium appeared histologically normal.
The immunohistochemical staining of CD31 showed 
positive staining in endothelial cells lining the capillaries 
(Fig.  3). There was no statistically significant difference 
in the areal percentage of the myocardium stained with 
CD31 between the remote myocardium and either the 
viable ischemic or the injured myocardium (Fig. 4).
The immunohistochemical staining of αvβ3 integrin 
was localized around the capillaries in the viable myo-
cardium, but also showed a diffuse distribution in the 
injured myocardium (Fig. 3). The areal percentage of the 
myocardium stained with αvβ3 integrin was higher in the 
injured area than in the remote myocardium (23 ± 1.9% 
vs. 7.5  ±  1.0%, p  <  0.001), but there was no difference 
between the viable ischemic myocardium (10 ± 4.0% vs. 
7.5 ± 1.0%, p = 0.15) and the remote area (Fig. 4).
There was intense α-SMA positive staining in the 
injured myocardium (Fig. 3). The area of the myocardium 
stained with α-SMA antibody was higher in the injured 
than in the remote area (7.2  ±  2.9% vs. 1.3  ±  0.75%, 
p = 0.019).
Radiochemical analyses and protein binding
The radiochemical purity and specific radioactivity of 
 [68Ga]NODAGA-RGD were  >99% and 35  ±  2.8  GBq/
µmol at the end of syntheses, respectively. The tracer 
Table 1 Cardiac  [15O]water and  [68Ga]NODAGA-RGD PET
The size of ischemic area based on  [15O]water PET during adenosine stress and myocardial  [68Ga]NODAGA-RGD uptake shown as standardized uptake value (SUV) in 
the remote myocardium, in the ischemic area and at the site of the highest uptake (Max) within the ischemic area
SUV standardized uptake value, LV left ventricle
* p = 0.0034 vs. remote
† p < 0.001 vs. remote
Animal [15O]water PET [68Ga]NODAGA-RGD PET
Ischemic area  
(% of the LV)
Remote  
SUVMean
Ischemic area  
SUVMean
Injured area  
SUVMax
1 19 0.68 0.71 0.95
2 17 0.37 0.56 0.67
3 35 0.52 0.70 1.11
4 32 0.47 0.56 0.74
5 19 0.36 0.54 0.72
6 36 0.65 0.79 0.94
7 37 0.42 0.41 0.59
8 43 0.45 0.57 0.70
Mean 30 0.49 0.61* 0.80†
SD 10 0.12 0.12 0.18
Fig. 3 Myocardial histology. Left panel representative image of 2,3,5‑triphenyltetrazolium chloride (TTC) staining. The arrows show the areas where 
the tissue samples of the injured area, viable ischemic area and remote area were collected. a–o demonstrate stainings of hematoxylin‑eosin (a–c) 
and Masson’s trichrome (d–f), and immunohistochemical stainings of CD31 (g–i), αvβ3 integrin (j–l) and α‑smooth muscle actin (m–o), and autora‑
diography (p–r) from the remote myocardium, from the viable ischemic area or injured myocardium based on TTC staining. Scale bar 50 µm
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remained stable in vivo throughout the PET imaging with 
the proportion of intact tracer being >98%. The plasma-
to-blood ratio of the tracer was 1.4 ±  0.10. The plasma 
free fraction was 0.94  ±  0.011 in the rat, 0.93  ±  0.017 
in the pig and 0.91 ±  0.081 in the human serum. Thus, 
binding of the tracer in the plasma proteins was low in all 
tested species.
[68Ga]NODAGA-RGD PET Imaging
Analysis of the  [68Ga]NODAGA-RGD PET images is 
demonstrated in Figs.  1 and 2, and time-activity curves 
are shown in Fig.  5. There was virtually no tracer 
uptake in the normal LV myocardium and tracer activ-
ity in the blood pool remained higher than myocardial 
activity throughout the imaging. Based on the  [15O]
water PET images, myocardial contours were drawn in 
the  [68Ga]NODAGA-RGD images to analyze regional 
tracer uptake. This demonstrated homogenous  [68Ga]
NODAGA-RGD distribution in sham operated pigs 
(coefficient of variation between segments 15  ±  6.3%), 
whereas uptake was regionally increased in all stented 
pigs within the ischemic area defined from the  [15O]
water perfusion imaging.
Mean and maximum myocardial  [68Ga]NODAGA-
RGD uptakes in the ischemic area and in the remote 
myocardium of stented pigs are shown in Table  1 and 
Fig. 6. In the ischemic area, the average myocardial  [68Ga]
NODAGA-RGD uptake was 26% higher than in the 
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remote myocardium (p =  0.003). The maximum uptake 
values inside the ischemic area of the pigs were 73 and 
46% higher than in the remote myocardium in pigs with 
viable ischemic or injured myocardium, respectively 
(p =  0.010 and p =  0.013, respectively, Table  1). There 
was no correlation between the size of the ischemic area 
and the amount of  [68Ga]NODAGA-RGD uptake. The 
average  [68Ga]NODAGA-RGD uptake in the LV myo-
cardium of the sham group was similar to the remote 
area of the stented pigs (SUV 0.42 ± 0.10 vs. 0.49 ± 0.12 
(p  =  0.38) and there was no difference in the uptake 
between the anteroseptal (segments 7 and 13) and pos-
terolateral (segment 11) walls in the sham group (SUV 
0.39 ± 0.11 vs. 0.36 ± 0.078, p = 0.28).
[68Ga]NODAGA-RGD ex vivo biodistribution
Ex vivo biodistribution studies (Fig.  6) showed that the 
radioactivity from  [68Ga]NODAGA-RGD was higher 
in the tissue sample obtained from the injured myocar-
dium (TTC negative) compared to the tissue sample 
obtained from the remote myocardium (SUV 0.79 ± 0.21 
vs. 0.49 ±  0.21, p =  0.016), but there was no difference 
between the samples obtained from the remote myocar-
dium and the viable ischemic (TTC positive) myocar-
dium (SUV 0.49 ± 0.17, p = 0.99).
[68Ga]NODAGA-RGD autoradiography
An autoradiography was performed on 6 pigs. The auto-
radiographs (Fig.  3) showed no  [68Ga]NODAGA-RGD 
uptake in tissue sections from the remote myocardium. 
Uptake was also very low in the viable ischemic myocar-
dium adjacent to the injured myocardium. In contrast, 
there were areas with clearly increased uptake in the 
sections containing injured myocardium. Quantitatively 
(Fig.  6), there was a statistically significant difference 
in the uptake between injured and remote myocar-
dium (p  =  0.006), whereas there was no difference in 
the uptake between viable ischemic myocardium and 
in the remote area (p =  0.82). The mean uptake values 
in the viable ischemic, remote, and injured areas were 
2.2 ±  0.85, 1.8 ±  0.61 and 4.6 ±  2.1 PSL/mm2, respec-
tively. The  [68Ga]NODAGA-RGD uptake measured by 
autoradiography positively correlated to the area per-
centage of αvβ3 integrin staining in the tissue sections 
 (rPearson = 0.73, p = 0.0013) (Fig. 4).
Discussion
The main findings of the present study are that  [68Ga]
NODAGA-RGD cardiac PET detected increased myocar-
dial αvβ3 integrin expression two weeks after induction 
of flow-limiting coronary stenosis in pig. In this model, 
αvβ3 integrin expression and  [68Ga]NODAGA-RGD 
uptake localized to the irreversibly injured myocardium, 
whereas tracer uptake was absent in viable ischemic 
areas. These results indicate that  [68Ga]NODAGA-RGD 
is a potentially sensitive tool to detect areas of recent 
myocardial injury in the presence of chronic ischemia. 
These findings have implications in evaluation of patients 
with chronic ischemic heart disease in whom a mixture 
of viable ischemic and injured myocardium exists in the 
absence of transmural scar [23]. Expression of αvβ3 inte-
grin appears to play a central role in cardiac repair fol-
lowing myocardial infarction. A recent study showed in 
patients with acute myocardial infarction that αvβ3 inte-
grin targeted tracer 18F-fluciclatide uptake was highest in 
segments with improved contractile function [24]. Thus, 
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imaging of αvβ3 integrin expression may have potential to 
predict functional recovery upon reperfusion [24, 25] or 
monitor effects of therapies aimed at accelerating repair 
of myocardial injury.
[68Ga]NODAGA-RGD is a novel PET tracer for imag-
ing αvβ3 integrin expression composed of a pentacyclic 
peptide binding moiety Arg-Gly-Asp-D-Tyr-Lys coupled 
with the gallium chelating agent NODAGA. The pre-
cursor can be obtained in Good Manufacturing Prac-
tices quality from a commercial supplier and the tracer 
is being developed for clinical use [26]. In addition to 
good target specificity, studies have indicated favorable 
kinetics, dosimetry and safety profile [27, 28]. In previ-
ous studies,  [68Ga]NODAGA-RGD uptake demonstrated 
αvβ3 integrin expression in infarcted rat myocardium 
1 week after coronary ligation [5]. Our study adds to the 
previous work by demonstrating that  [68Ga]NODAGA-
RGD cardiac PET detected αvβ3 integrin expression in 
small, mainly subendocardial areas of myocardial injury 
in a model of chronic ischemia. We used a bottleneck 
stent model to induce persistent flow-limiting stenosis 
in pigs. Pig offers several advantages in comparison to 
rodent models as a model of translational cardiovascu-
lar research. The heart and the coronary artery system of 
pigs are almost identical to those of humans [29]. The size 
of the pig heart, which is more comparable to the size of 
the human heart than the heart of rodents, enables the 
use of clinical scanner and more reliable discrimination 
between the injured and ischemic myocardial areas. As 
shown earlier in this model, stent implantation imme-
diately causes severe reduction in blood flow in the tar-
get coronary artery as shown by reduced fractional flow 
reserve, reduced myocardial blood flow during adeno-
sine stress, and rapid collateral growth [19]. Although 
antithrombotic therapy was continued throughout the 
study to prevent stent occlusion, areas of organizing 
injury were detected in 6 animals. This may have been 
caused by insufficient compensation for reduction in 
myocardial perfusion by collateral formation, occlusion 
of a side branch by the stent, or thrombosis within the 
stent [19].
Repair following myocardial injury is triggered by a 
complex interaction of neurohormonal activation and 
upregulation of local paracrine signaling mechanisms 
that initiate restoration of capillary network through 
angiogenesis and extracellular matrix remodeling 
through macrophage accumulation and fibroblast acti-
vation. Expression of αvβ3 integrin by vascular endothe-
lial cells mediates angiogenesis, but also plays a role in 
regulation of macrophage inflammatory responses and 
myofibroblast differentiation during this process [16–18]. 
Thus, αvβ3 integrin is a potential marker of repair follow-
ing myocardial infarction. One main finding of our study 
is that  [68Ga]NODAGA-RGD uptake was localized in the 
irreversibly damaged myocardial regions, but not in the 
adjacent viable myocardium within the ischemic area 
in this model. Increased expression of αvβ3 integrin was 
confirmed by immunohistochemical staining, the amount 
of which correlated with  [68Ga]NODAGA-RGD uptake 
in myocardial tissue samples. In the injured myocardium, 
staining of αvβ3 integrin was diffuse among fibroblasts 
and inflammatory cells, and staining of α-SMA demon-
strated myofibroblast differentiation, whereas endothelial 
cell staining with CD31 antibody demonstrated no dif-
ference in capillary density between remote, ischemic, 
and infarcted myocardium. These findings indicate that 
αvβ3 integrin expression and  [68Ga]NODAGA-RGD 
uptake reflected not only angiogenesis, but other pro-
cesses related to scar formation. These findings are in 
line with a previous study that did not find evidence of 
enhanced angiogenesis or uptake of 123I-labelled cyclo(-
Arg-Gly-Asp-D-Tyr-Lys(3-acetamido-2,6-anhydro-3-
deoxy-β-d-glycero-d-gulo-heptanoic acid) (Gluco-RGD) 
in a pig model of myocardial hibernation induced by an 
ameroid constrictor [30]. Previous studies have shown 
RGD uptake and angiogenesis in severely hypoxic tissue 
[9, 12], but the severity and duration of the ischemia in 
the viable ischemic myocardium in our model were prob-
ably not sufficient to induce these.
We acknowledge that there are some limitations 
associated with our study. One of these is the fact 
that we did not test the effects of therapeutic angio-
genesis on  [68Ga]NODAGA-RGD uptake. Angiogen-
esis induced with gene therapy has previously been 
detected with  [123I]-Gluco-RGD in hibernating pig 
myocardium, where spontaneous ischemia did not 
induce angiogenesis [30] and with  [18F]-alfatide II 
 ([18F]-AlF-NOTA-E[PEG4-c(RGDfk)]2) in rats after myo-
cardial infarction [31]. Another limitation is that we used 
only one time point based on previous studies showing a 
peak in αvβ3 integrin expression and RGD uptake between 
1 and 4  weeks after an ischemic insult [3, 4, 6, 16]. 
We also acknowledge the small sample size in our study, 
especially relating to the autoradiography. Also the use 
of two different PET/CT scanners for  [15O]water and 
 [68Ga]NODAGA-RGD imaging due to logistic reasons 
is a limitation and might affect the accuracy of the co-
registration of the images. Adenosine dose was adjusted 
in some pigs due to variable systemic hemodynamic 
responses. It has been shown that dipyridamole may pro-
vide stronger hyperemic response in the pig heart [32]. 
Respiratory and cardiac motion may affect sensitivity of 
 [68Ga]NODAGA-RGD due to activity in the closely asso-
ciated blood pool. Myocardial  [68Ga]NODAGA-RGD 
uptake was studied at 50-60  min after injection, when 
blood levels were lower than 5% of their peak. Consistent 
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with previous studies [24],  [68Ga]NODAGA-RGD radio-
activity remained higher in the blood than in the normal 
myocardium. In order to avoid spill over from the right 
ventricle influencing our results we included only seg-
ments in the mid-anterolateral and posterior wall into 
the in  vivo PET analysis. Integrin αvβ3 can be found on 
platelets, albeit in low concentrations [33]. Platelet count 
in pigs is much higher than that of humans [34] that 
might result in higher blood radioactivity in pigs than in 
human. However, we did not find any species differences 
in the binding of the tracer to plasma proteins between 
pigs, rats and humans.
Conclusions
[68Ga]NODAGA-RGD cardiac PET demonstrates 
increased myocardial αvβ3 integrin expression in a pig 
model of coronary stenosis. Increased αvβ3 integrin 
expression is localized in the irreversibly injured myocar-
dium, whereas it is absent in viable myocardium within 
the ischemic area.  [68Ga]NODAGA-RGD PET may be 
useful for the identification of αvβ3 integrin activation 
associated with repair of myocardial injury in the pres-
ence of coronary stenosis.
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